Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)

NCT00058591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus Infections

Interventions

BIOLOGICAL: Intravenous injection of EBV specific CTLS

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]